Citations Please use one of the following formats to cite this article in your essay, paper or report: APA Khetrapal, Afsaneh
However, compared to the health costs associated with obesity-related conditions (diabetes management, cardiovascular medications, joint replacements), many people find the investment worthwhile
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
6 months and beyond: Continued weight loss and blood sugar management are common, especially when paired with a healthy lifestyle
Give it time , specifically 8 to 12 weeks for the most significant changes